BDBM50204957 2-(5-((2-acetamidothiazol-4-yl)methyl)-4-(4-chlorobenzamido)-4H-1,2,4-triazol-3-ylthio)acetohydrazide::CHEMBL233491::N-{3-({2-[(acetyl)amino]-1,3-thiazol-4-yl}methyl)-5-[(2-hydrazino-2-oxoethyl) sulfanyl]-4H-1,2,4-triazol-4-yl}-4-chlorobenzamide

SMILES CC(=O)Nc1nc(Cc2nnc(SCC(=O)NN)n2NC(=O)c2ccc(Cl)cc2)cs1

InChI Key InChIKey=QIYYNXDEQKBHEH-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50204957   

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1/G1/S-specific cyclin-E2(Homo sapiens (Human))
Dr. Reddys Laboratories

Curated by ChEMBL
LigandPNGBDBM50204957(2-(5-((2-acetamidothiazol-4-yl)methyl)-4-(4-chloro...)
Affinity DataIC50:  624nMAssay Description:Inhibition of human cdk2/cyclin E by SPAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase 5 activator 1(Homo sapiens (Human))
Dr. Reddys Laboratories

Curated by ChEMBL
LigandPNGBDBM50204957(2-(5-((2-acetamidothiazol-4-yl)methyl)-4-(4-chloro...)
Affinity DataIC50:  72nMAssay Description:Inhibition of human cdk5/p25 by SPAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed